Quantcast

Latest Tel Aviv Stock Exchange Stories

2014-06-16 08:28:54

TEL AVIV, Israel, June 16, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that it has been notified by the Tel Aviv Stock Exchange that BioLight will be included in the Tel Aviv Biomed Index (TA-Biomed) and also in the Tel Aviv BlueTech index (TA- BlueTech), effective June 15, 2014. The...

2014-06-12 08:29:12

Company Must Remedy Noncompliance with Audit Committee Requirements as Set Forth in Listing Rule 5605 HERZLIYA, Israel, June 12, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") dated...

2014-06-12 08:22:31

TEL-AVIV, Israel, June 12, 2014 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE MKT: ELLO)(TASE: ELOM) ("Ellomay" or the "Company"), an emerging operator in the renewable energy and energy infrastructure sector, today announced a private placement of NIS 80.341 million par value of its unsecured non-convertible Series A debentures (the "Additional Series A Debentures") to Israeli classified investors for an aggregate consideration of approximately NIS 81.1 million (approximately...

2014-06-08 08:20:28

TEL-AVIV, Israel, June 8, 2014 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE MKT: ELLO; TASE: ELOM) ("Ellomay" or the "Company") an emerging operator in the renewable energy and energy infrastructure sector, today announced that Standard & Poors Maalot Ltd., an Israeli rating company affiliated with Standard & Poors, assigned its ilA- rating in connection with the potential issuance up to NIS 80 million par value additional unsecured non-convertible Series A debentures of the...

2014-06-02 08:36:14

NETANYA, Israel, June 2, 2014 /PRNewswire/ -- Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company") announced that its Board of Directors has instructed the Company to commence preparations for raising debt by offering to the public, in Israel only, two new series of debentures. In preparation to the potential offering of debentures the Company published to the public in Israel a draft indenture. The execution, timing, terms and amount of such contemplated...

2014-05-30 16:25:10

PETACH TIKVA, Israel, May 30, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced that its 2014 Annual General Meeting of Shareholders will be held on Monday, July 7, 2014 at 10.00 a.m. (Israel time) at the offices of the Company, 10 Bareket Street, Petach Tikva, Israel. The record date for shareholders entitled to vote at the...

2014-05-29 12:23:34

TEL AVIV, Israel, May 29, 2014 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG, OTCQX: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results for the three month period ending March 31, 2014. The full financial statements are available in English on Delek Group's website at: www.delek-group.com. FIRST QUARTER 2014 HIGHLIGHTS -- Delek Group continued to complete a number of strategic steps to increase focus on its E&P assets; signed an agreement to...

2014-05-29 08:28:52

PETACH TIKVA, Israel, May 29, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported financial results for the first quarter ended March 31, 2014. Dr. Pnina Fishman, CEO of Can-Fite stated, "During the first quarter of 2014 we applied for, and received approval from the Institutional Review Board in Israel for our Phase II study...

2014-05-27 16:20:46

GEDERA, Israel, May 27, 2014 /PRNewswire/ -- TAT Technologies Ltd. (NASDAQ: TATT), today announced that it has scheduled an annual and extraordinary general meeting of shareholders, to take place on Wednesday, July 9, 2014, at 5:00 p.m. Israel time, at the offices of Naschitz, Brandes, Amir & Co., Advocates, located at 5 Tuval Street, Tel-Aviv, Israel. The record date for the meeting is June 5, 2014. The agenda of the Meeting shall be as follows: 1. Approval...

2014-05-27 04:22:32

Provider of Innovative Insurance Software Solutions Scheduled to Present on Wednesday, June 11, 2014 - 08:00 AM HOLON, Israel, May 27, 2014 /PRNewswire/ -- Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry with an emerging focus on the broader financial services sector, announced today that Roni Al-Dor, chief executive officer, and Roni Giladi, chief financial officer, will present at the William...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related